**Core Concept**
The question is testing the understanding of antibiotic resistance mechanisms in non-fermenting gram-negative bacteria, specifically Pseudomonas and Burkholderia. These organisms are notorious for their ability to develop resistance to multiple antibiotics, posing a significant challenge in clinical management.

**Why the Correct Answer is Right**
The correct answer is related to the unique resistance mechanism exhibited by these organisms. Pseudomonas and Burkholderia are known to exhibit carbapenem resistance through the production of metallo-beta-lactamases (MBLs), such as the NDM-1 enzyme. This enzyme hydrolyzes carbapenems, rendering them ineffective against these bacteria. The production of MBLs is a key factor differentiating the resistance profiles of Pseudomonas and Burkholderia from other non-fermenting gram-negative bacteria.

**Why Each Wrong Option is Incorrect**
* **Option A:** Resistance to fluoroquinolones is not a unique characteristic of Pseudomonas and Burkholderia, as many other gram-negative bacteria also exhibit resistance to this class of antibiotics.
* **Option B:** Extended-spectrum beta-lactamases (ESBLs) are indeed a resistance mechanism exhibited by Pseudomonas and Burkholderia, but they are not the key factor differentiating their resistance profiles from other non-fermenting gram-negative bacteria.
* **Option C:** Aminoglycoside modifying enzymes are not a unique characteristic of Pseudomonas and Burkholderia, as many other gram-negative bacteria also exhibit resistance to aminoglycosides through this mechanism.

**Clinical Pearl / High-Yield Fact**
It is essential to remember that the production of metallo-beta-lactamases, such as NDM-1, is a key factor in the carbapenem resistance exhibited by Pseudomonas and Burkholderia. This knowledge is crucial for selecting appropriate antibiotic therapy in clinical scenarios where these organisms are suspected or confirmed.

**Correct Answer:** C.